KR920016461A - New Platinum (II) Complexes and Malignant Tumors - Google Patents

New Platinum (II) Complexes and Malignant Tumors Download PDF

Info

Publication number
KR920016461A
KR920016461A KR1019910003310A KR910003310A KR920016461A KR 920016461 A KR920016461 A KR 920016461A KR 1019910003310 A KR1019910003310 A KR 1019910003310A KR 910003310 A KR910003310 A KR 910003310A KR 920016461 A KR920016461 A KR 920016461A
Authority
KR
South Korea
Prior art keywords
platinum
malignant tumors
complexes
complex
novel platinum
Prior art date
Application number
KR1019910003310A
Other languages
Korean (ko)
Other versions
KR960005023B1 (en
Inventor
고오 하타
마사토 무토오
히데유키 하시모토
Original Assignee
마에다 카츠노스케
도오레 가부시기가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 마에다 카츠노스케, 도오레 가부시기가이샤 filed Critical 마에다 카츠노스케
Priority to KR1019910003310A priority Critical patent/KR960005023B1/en
Publication of KR920016461A publication Critical patent/KR920016461A/en
Application granted granted Critical
Publication of KR960005023B1 publication Critical patent/KR960005023B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F15/00Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/555Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00Medicinal preparations containing inorganic active ingredients
    • A61K33/24Heavy metals; Compounds thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)

Abstract

내용 없음No content

Description

신규 백금(Ⅱ)착체 및 악성종양 치료제New Platinum (II) Complexes and Malignant Tumors

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음Since this is an open matter, no full text was included.

Claims (5)

R1은 탄소수 1-5의 저급탄화수소기, R2,R3는 수소원자 또는 탄소수 1-3의 저급탄화수소기를 표시하며, 1,2-디아미노시클로핵산의 입체배치는, 시스, 트랜스-ℓ-혹은 트랜스-d-플 표시하는 일반식R 1 represents a lower hydrocarbon group of 1-5 carbon atoms, R 2 , R 3 represents a hydrogen atom or a lower hydrocarbon group of 1-3 carbon atoms, and the stereoconfiguration of 1,2-diaminocyclonucleic acid is cis, trans- -Or trans-d-full formula 으로 나타내는 것을 특징으로 하는 신규백금(Ⅱ)착체.New platinum (II) complex, characterized in that represented by. 제1항에 있어서, R1이 메틸기인 것을 특징으로 하는 신규백금(Ⅱ)착체.The novel platinum (II) complex according to claim 1, wherein R 1 is a methyl group. 제1항에 있어서, R2,R3가 수소원자 또는 메틸기인 것을 특징으로 하는 신규백금(Ⅱ)착체.The novel platinum (II) complex according to claim 1, wherein R 2 and R 3 are hydrogen atoms or methyl groups. 제3항에 있어서, R2가 수소원자, R3가 메틸기인 것을 특징으로 하는 신규백금(Ⅱ)착체.The novel platinum (II) complex according to claim 3, wherein R 2 is a hydrogen atom and R 3 is a methyl group. 제1항 내지 제4항의 신규백금착체(Ⅱ)를 유효성분으로 하는 것을 특징으로 하는 악성종양치료제.A therapeutic agent for malignant tumors, comprising the novel platinum complex (II) of claim 1 as an active ingredient. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019910003310A 1991-02-28 1991-02-28 Novel platinum(ñœ)complex and drug for treating malignant tumor KR960005023B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910003310A KR960005023B1 (en) 1991-02-28 1991-02-28 Novel platinum(ñœ)complex and drug for treating malignant tumor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910003310A KR960005023B1 (en) 1991-02-28 1991-02-28 Novel platinum(ñœ)complex and drug for treating malignant tumor

Publications (2)

Publication Number Publication Date
KR920016461A true KR920016461A (en) 1992-09-24
KR960005023B1 KR960005023B1 (en) 1996-04-18

Family

ID=19311642

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910003310A KR960005023B1 (en) 1991-02-28 1991-02-28 Novel platinum(ñœ)complex and drug for treating malignant tumor

Country Status (1)

Country Link
KR (1) KR960005023B1 (en)

Also Published As

Publication number Publication date
KR960005023B1 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
KR870008576A (en) Hair wave
KR890008086A (en) Cyclohexane derivatives
FR2681784B1 (en) DERMATOLOGICAL AND / OR COSMETOLOGICAL COMPOSITION CONTAINING RETINOUIDES AND USE OF NEW RETINOUIDES.
KR890014098A (en) Prophylaxis and treatment of central neurodegenerative diseases containing catechol amine derivatives
KR870008824A (en) Difluorohalomethoxyphenyl derivatives and acaricides containing the same as active ingredients
KR870011182A (en) Modifiers for Synthetic Resins
KR880009982A (en) Platinum complex
KR890014107A (en) Platinum Chemotherapy
KR890014480A (en) 2-pyridylacetic acid derivative, preparation method thereof and pharmaceutical composition containing same
KR870005968A (en) Amide derivatives and external preparations containing the same
KR890014536A (en) Condensed quinoline compounds, condensed acridine compounds, methods for preparing the same, and anticancer compositions containing the same
KR920701220A (en) New binuclear platinum complex and antitumor agent using the same
KR850700108A (en) Anti-tumor pharmaceutical composition and preparation method thereof
KR920016461A (en) New Platinum (II) Complexes and Malignant Tumors
ES8507110A1 (en) Indolylacetic acid derivatives and preparations containing same for medical treatments.
KR910005860A (en) Anti Liver Disease Composition
KR920701221A (en) Novel platinum complexes and antitumor agents using the same
KR920008012A (en) Triazole derivatives
KR920002706A (en) Anaerobic Curable Composition
KR900016184A (en) 1,3-dioxane derivative
KR900018040A (en) Novel pyrazole sulfonate derivatives with physiological activity
KR920019349A (en) Use of R (+)-3-amino-1-hydroxy-pyrrolidin-2-one to treat anxiety
KR850004888A (en) Agricultural Sterilization Composition
KR920009792A (en) Method for preparing 3-amino-4-methylenepyrrolidine derivative
KR890009877A (en) Method for preparing 1-acyl-2-pyrazoline derivative

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20010411

Year of fee payment: 6

LAPS Lapse due to unpaid annual fee